Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thx guys! Got a little (a lot actually) scared for a minute!!
Agreed- I'm thinking we hit $14.50 at some point Monday
Yes very positive. This should move up on Tuesday. At first there was some confusion hence the pps fall until a second update.
Invest - was the labelling positive then? Is that one of the reasons why it rebounded AH?
I have 13.02/13.71 Bid/Ask on my streamer which is usually 99% accurate
There were two separate announcements that came out today. Most investors got screwed using their stop loss. This is from my scottrade; First news came out was the FDA approval. I thought it was a little weird that trading wasn't halted or why they chose to have it announced without the labeling information. The 2nd news came 50 minutes later (which I can only assume by this point that most people have already lost their money due to their stop loss) regarding the label which everyone was probably confused about. Why didn't they put out the news at the same time? Who knows, but the short covering may possibly start on Tuesday.
Enjoy your BBQ on Monday folks.
I see that almost every day on I-Hub quotes though. After hours last trade for many stocks is like .000000000001 and it says the stock is down 99.9999% for the day
no, not glitch in ihub. the ticklers will show the right bid and ask when the market opens. it's rather common.
So its probably a glitch in ihub right??
thats not relevant as the market is closed
Why did it go to 0.00 after hours?!?! What happened?? Please someone tell me!!!!
"The recognition in our label of the DIFICID superiority in sustained clinical response will allow the Optimer and Cubist field force to educate the medical community about the advantage DIFICID can offer to appropriate CDAD patients."
FDA Approves Optimer's DIFICID (fidaxomicin) Tablets for the Treatment of Patients with Clostridium difficile-Associated Diarrhea (CDAD)
- In two CDAD clinical trials, DIFICID was non-inferior to vancomycin in clinical response at the end of therapy and superior to vancomycin in sustained clinical response 25 days post-treatment -
Optimer to host conference call for investors on May 31st at 8:00 a.m. Eastern Daylight Time
http://finance.yahoo.com/news/FDA-Approves-Optimers-DIFICID-prnews-2426970119.html?x=0&.v=1
Took a bunch of profits yesterday and then did something that I dont normally do. I took some of my profits and bought 30 June $15 Calls at .20
Gonna see how they play out. Anyone have any thoughts on whats going to happen here Tuesday?
Have a great weekend all.
I just sold some shares @ 13.77 which I just bought @ 12.80 during the raid just in case. I am not letting go of the rest. Tuesday this will rock IMO!
Label out clearly stating superiority etc etc
I got 13.67 Ask of 13.67
Man! I just had to crack open a Michelob Ultra!
Wow what the heck was that. Luckily I had a low order in or I would of got screwed. We'll see what happens on Tuesday
Bear raid on approval because I cannot find anything regarding labeling.
FDA NEWS RELEASE
For Immediate Release: May 27, 2011
Media Inquiries: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA
FDA approves treatment for Clostridium difficile infection
The U.S. Food and Drug Administration today approved Dificid (fidaxomicin)
tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD).
Clostridium difficile (C. difficile) is a bacterium that can cause diarrhea
and lead to colitis, other serious intestinal conditions, and death in severe
cases. C. difficile bacteria are found in the stool of an infected person, and
others can become infected if they touch items or surfaces contaminated with
the bacteria or spores and then touch their mouths.
The safety and efficacy of Dificid were demonstrated in two trials that
included 564 patients with CDAD that compared Dificid with vancomycin, a common
antibiotic used to treat CDAD. The clinical response was similar in the Dificid
group compared with the vancomycin group in both studies. In some patients with
CDAD, symptoms can return. In the Dificid trials, a greater number of patients
treated with Dificid had a sustained cure three weeks after treatment ended
versus those patients treated with vancomycin.
"In recent years, many in the infectious disease community have seen an
increase in the number of cases of people with a C. difficile infection," said
Edward Cox, M.D., M.P.H., director of the Office of Antimicrobial Products in
the FDA's Center for Drug Evaluation and Research. "Dificid is an effective new
treatment option for patients who develop Clostridium difficile-associated
diarrhea."
Dificid, a macrolide antibacterial, should be taken two times a day for 10
days with or without food.
To maintain the effectiveness of Dificid, and to reduce the development of
drug-resistant bacteria, the drug should be used only to treat infections that
are proven or strongly suspected to be caused by C. difficile.
The most common side effects reported with Dificid included nausea, vomiting,
headache, abdominal pain, and diarrhea.
People at risk of developing the bacterial infection include the elderly,
patients in hospitals or nursing homes, and people taking antibiotics for
another infection. The most effective way to prevent CDAD is thorough
handwashing with soap and warm water.
Dificid was developed by San Diego-based Optimer Pharmaceuticals Inc.
For more information:
CDC: Prevent Clostridium difficile Infection1
Approved Drugs: Questions and Answers2
The FDA, an agency within the U.S. Department of Health and Human Services,
protects the public health by assuring the safety, effectiveness, and security
of human and veterinary drugs, vaccines and other biological products for human
use, and medical devices. The agency also is responsible for the safety and
security of our nation's food supply, cosmetics, dietary supplements, products
that give off electronic radiation, and for regulating tobacco products.
#
(END) Dow Jones Newswires
05-27-11 1519ET
15:19 052711
To anyone's knowledge has a bear raid ever been done after hours?
14.10 and dropping but still doesn't appear to be a bear raid.
FDA decision TODAY: http://bit.ly/jlJNSe
14.40 we are moving now!
No signs of a bear raid.
Yes I'd like to get this over with ASAP. I can't take another SPPI watching my streamer till 8:00 at night.
Yep, the price is all over the place today.
Buys are coming in fairly quickly now in anticipation of the news.
Folks do not want to be left out over the long weekend.
I would like the news today as I will be busy early next week.
I see it's moving fast! I just put an order in for a Bear Raid just in case.
VOLUME is starting to pickup. 744,000 shares in the first 2 hrs.
The Next Big Thing In Biotech: OPTR
http://www.thestreet.com/_yahoo/video/11135633/the-next-big-thing-in-biotech-optr.html?cm_ven=YAHOOV&cm_cat=FREE&cm_ite=NA&s=1#962464016001
We should know the answer soon enough..
I'm hoping tonight or tomorrow morning so i don't have to wait till tuesday.....
It's definitely not a coincidence he is short! Maybe he's sweating it out now.
I think they did that to me when i was in HGSI at 2.50, got approval for lupus , went over 11.00 that day..
No one knows...
Good, when we are right we can LAUGH at them...
Yes I noticed that. Seeking Alpha does it again.
Notice how the article writer has disclosed he's a SHORT..
I wonder how slanted this article is?
It looks like they are getting ready for a Bear Raid judging by a couple of articles just put out today. At least they are starting early this time.
http://seekingalpha.com/article/272054-labeling-and-script-use-may-cause-problems-for-optimer-s-new-drug
I kinda agree,the price is way too high for a company with no products or sales already Im second guessing a run past $15 after possible approval.
Bear raid thoughts.... i actually think there isn't going to be a bear raid but never know...
Yes I agree totally! Anticipation...tick tock...
Friday night or monday approval would be weak ..
I'm really hoping for sometime today or tomorrow at the latest
How about today? That would be nice. Friday would be too much with the Holiday coming up unless it happened early in the day.
I would not like to see another late Friday night approval like SPPI
10% shorted , meaning a good amount of people don't believe its going to happen...
This is also why i don't want the news coming out monday or even friday, there will no volume!!!
I bought in @ 12, been here a while. Its just trading lite shares for getting approval this week. JMO
Don't know but stock has been trading GREAT if you are long for the last few weeks..
10% of this stock is shorted and if approved stock will run and then shorts will be covering to run this stock even higher, imo
Followers
|
4
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
320
|
Created
|
08/23/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |